title: Targeted disruption of the mouse mdr1b gene reveals that steroid hormones enhance mdr gene expression.
abstract: To evaluate the role of P-glycoprotein in steroid secretion in adrenal cells, we have used gene targeting to introduce a null mutation into one allele of the mdr1b gene in mouse Y1 adrenal cells. Characterization of both the wild-type and the mutant cell lines revealed the following. 1) The expression of mdr1b is enhanced by steroid hormones, in a feedback regulatory mechanism. Inhibition of steroid biosynthesis by 2-aminoglutethimide blocks the adrenocorticotropin (ACTH)-induced increase in mdr1b mRNA levels. 2) ACTH-stimulated steroid secretion is markedly decreased in the mutant cell line. This decreased steroid secretion in the mutant cells occurs despite an increase in the levels of mdr1b mRNA and P-glycoprotein. Kinetic analyses of vinblastine and daunomycin accumulation in both the wild-type and the mutant cell lines during ACTH-stimulated steroidogenesis show that in the mutant cells both drugs accumulated to higher levels than in Y1 cells, suggesting that the remaining mdr1b allele in the mutant cells is relatively inactive as an exporter of steroids, or that the targeted disruption of the mdr1b allele is associated with other changes in the mutant cells which block ACTH-stimulated steroid secretion.
authors.affiliation: Laboratory of Cell Biology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892.
authors.forename: S
authors.initials: S
authors.lastname: Altuvia
authors.forename: W D
authors.initials: WD
authors.lastname: Stein
authors.forename: S
authors.initials: S
authors.lastname: Goldenberg
authors.forename: S E
authors.initials: SE
authors.lastname: Kane
authors.forename: I
authors.initials: I
authors.lastname: Pastan
authors.forename: M M
authors.initials: MM
authors.lastname: Gottesman
mesh_terms: D015124:8-Bromo Cyclic Adenosine Monophosphate / Q000494:pharmacology; D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; D000311:Adrenal Glands / Q000166:cytology / Q000187:drug effects / Q000378:metabolism; D000324:Adrenocorticotropic Hormone / Q000494:pharmacology; D000818:Animals; D002352:Carrier Proteins / Q000235:genetics* / Q000502:physiology; D002460:Cell Line; D003630:Daunorubicin / Q000378:metabolism; D004351:Drug Resistance / Q000235:genetics; D005786:Gene Expression Regulation; D006728:Hormones / Q000378:metabolism / Q000502:physiology*; D008562:Membrane Glycoproteins / Q000235:genetics* / Q000502:physiology; D051379:Mice; D009154:Mutation; D012333:RNA, Messenger / Q000378:metabolism; D013256:Steroids / Q000502:physiology*; D014747:Vinblastine / Q000378:metabolism
chemical_list: D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; D002352:Carrier Proteins; D006728:Hormones; D008562:Membrane Glycoproteins; D012333:RNA, Messenger; D013256:Steroids; D015124:8-Bromo Cyclic Adenosine Monophosphate; D014747:Vinblastine; D000324:Adrenocorticotropic Hormone; D003630:Daunorubicin